Stages of the clinical testing, setting up the process of testing, characteristics of clinical testing, medical ethics in testing process, participation in the clinical testing. Testing of new medical impact among...

When to start antiretroviral therapy? Recommended schemes of first-line therapy for adults. Reasons to change antiretroviral therapy. The choice of schemes of second-line therapy. Considering certain groups of...

Statistics. Siberian Network of AIDS-service organizations, Siberian District Center f the Ministry of Healthcare on prevention and fight against AIDS, information about epidemiologic situation on HIV-infection....

Immune system and number of CD4. Virusology, HIV and viral load. Introduction to the ARV - therapy. Side effects of ARV drugs. Opportunistic infections and co-infections, HIV and pregnancy. Injection drug users and...

Brazil: access of injection drug users to highly-active antiretroviral therapy as response to the epidemic of HIV/AIDS. Barcelona: changing attitude and approach towards drug abuse and public health care. Baltimore:...

Background information. Initiative “3 by 5”. Strategic scheme. To achieve results: changes in WHO. Working with partners. Key figures for indicators of global monitoring of the Initiative “3 to 5”.

The problem of forming adherence to treatment. Medicines. Patient. Environs. Interventions aimed at improving adherence to ARV treatment. The system of social assistance (follow-up) in narcology. Direct-observed...

The following issues are discussed: Issues of primary concern: What? When? Why?; Adherence to ARV-therapy: why is it so important?; Adherence Diary; drug resistance; How medicines are prescribed, and what are their...